Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26496
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRepchuk, Yuliya-
dc.contributor.authorSydorchuk, Larysa-
dc.contributor.authorFedoniuk, Larysa-
dc.contributor.authorNebesna, Zoia-
dc.contributor.authorVasiuk, Valentyna-
dc.contributor.authorSydorchuk, Andrii-
dc.contributor.authorIftoda, Oksana-
dc.date.accessioned2025-04-25T08:34:37Z-
dc.date.available2025-04-25T08:34:37Z-
dc.date.issued2021-
dc.identifier.otherDOI: 10.3889/oamjms.2021.6975-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26496-
dc.description.abstractAIM: The purpose of this study was to analyze lipid metabolism changes in patients with EAH depending on the Vitamin D receptor (VDR rs2228570 (aka rs10735810)) and angiotensinogen (AGT rs699) genes polymorphism. CONCLUSIONS: The EAH risk increases with a reduced HDL-C level in the TC genotype carriers of the AGT gene and irrespective of VDR gene polymorphic variants.uk_UA
dc.language.isoenuk_UA
dc.publisherOpen Access Macedonian Journal of Medical Sciences (медичний науковий журнал)uk_UA
dc.subjectLipidsuk_UA
dc.subjectCholesteroluk_UA
dc.subjectVitamin D receptor gene (VDR rs10735810, rs222857)uk_UA
dc.subjectAngiotensinogen gene (AGT rs699)uk_UA
dc.subjectArterial hypertensionuk_UA
dc.titleAssociation of Lipids’ Metabolism with Vitamin D Receptor (rs10735810, rs222857) and Angiotensinogen (rs699) Genes Polymorphism in Essential Hypertensive Patientsuk_UA
dc.typeArticleuk_UA
Appears in Collections:Статті. Кафедра гігієни та екології

Files in This Item:
File Description SizeFormat 
Yuliya Repchuk et al.Assotiation_1052-1056.pdf161.02 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.